SPL 1.03% 9.6¢ starpharma holdings limited

Nintedanib - Nintedanib/Docetaxel - Nintedanib/DepDocetaxel, page-19

  1. 1,792 Posts.
    lightbulb Created with Sketch. 321
    In a word Smurf - expectation.
    Some investors were led to believe the product was ready to go by March. Then in April we were told, in a company presentation to new investors, that it could be available in a couple of months.
    That was our expectation, and it is not being realised. So the real question on the minds of some investors is "When the #@$! will it be on the market".
    Nobody doubts that it will, but there is so little info coming from the company, and what there is appears to be badly inaccurate.
    Personally, I hit the big 60 this week. I had hoped to relax comfortably into retirement with a nice SPL capital gain to offset my other losses over the tax year. Doesn't look like that will happen, hence my personal frustration. I am sure other investors have their own reasons.
    But that is nothing compared to those suffering with BV or, even worse, some form of cancer. I wonder if they are happy to "just chill"
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
-0.001(1.03%)
Mkt cap ! $39.58M
Open High Low Value Volume
9.7¢ 10.5¢ 9.6¢ $97.41K 997.8K

Buyers (Bids)

No. Vol. Price($)
2 106430 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 5108 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.